| Fentanyl | 🇺🇸États-Unis | 0.1MG BASE, 0.2MG BASE, 0.3MG BASE … | troche/lozenge | Non commercialisé | Cephalon |
| Fentanyl | 🇺🇸États-Unis | 100MCG, 200MCG, 300MCG … | tablet | Approbation provisoire | Mylan Pharms INC |
| Fentanyl-12 | 🇺🇸États-Unis | 12.5MCG/HR | film, extended release | Commercialisé | Specgx LLC |
| Fentanyl-25 | 🇺🇸États-Unis | 25MCG/HR | film, extended release | Commercialisé | Lavipharm Labs |
| Fentanyl-37 | 🇺🇸États-Unis | 37.5MCG/HR | film, extended release | Commercialisé | Specgx LLC |
| Fentanyl-50 | 🇺🇸États-Unis | 50MCG/HR | film, extended release | Commercialisé | Lavipharm Labs |
| Fentanyl-62 | 🇺🇸États-Unis | 62.5MCG/HR | film, extended release | Commercialisé | Specgx LLC |
| Fentanyl-75 | 🇺🇸États-Unis | 75MCG/HR | film, extended release | Commercialisé | Lavipharm Labs |
| Fentanyl-87 | 🇺🇸États-Unis | 87.5MCG/HR | film, extended release | Commercialisé | Difgen Pharms |
| Fentanyl-100 | 🇺🇸États-Unis | 100MCG/HR | film, extended release | Commercialisé | Lavipharm Labs |
| Fentanyl Citrate | 🇺🇸États-Unis | 0.025MG BASE/0.5ML, 0.05MG BASE/ML | injectable | Commercialisé | Hospira |
| Fentanyl Citrate | 🇺🇸États-Unis | 2.5MG BASE/50ML (EQ 0.05MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 5MG BASE/100ML (EQ 0.05MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | solution | Non commercialisé | Exela Pharma |
| Fentanyl Citrate | 🇺🇸États-Unis | 0.2MG BASE, 0.4MG BASE, 0.6MG BASE … | troche/lozenge | Non commercialisé | Par Pharm |
| Fentanyl Citrate | 🇺🇸États-Unis | 0.1MG BASE, 0.2MG BASE, 0.3MG BASE … | tablet | Non commercialisé | Watson Labs |
| Fentanyl Citrate | 🇺🇸États-Unis | 0.1MG BASE, 0.2MG BASE, 0.3MG BASE … | tablet | Non commercialisé | Actavis Labs FL INC |
| Fentanyl Citrate Preservative Free | 🇺🇸États-Unis | 0.05MG BASE/ML | injectable | Commercialisé | DR Reddys |
| Fentanyl Citrate and DroperidolAssociation | 🇺🇸États-Unis | 2.5MG/ML; 0.05MG BASE/ML | injectable | Non commercialisé | Hospira |
| Fentora | 🇺🇸États-Unis | 0.1MG BASE, 0.2MG BASE, 0.3MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** … | tablet | Non commercialisé | Cephalon |
| Sublimaze Preservative Free | 🇺🇸États-Unis | 0.05MG BASE/ML | injectable | Commercialisé | Rising |
| Actiq | 🇺🇸États-Unis | 0.2MG BASE, 0.4MG BASE, 0.6MG BASE … | troche/lozenge | Non commercialisé | Cephalon |
| Abstral | 🇺🇸États-Unis | 0.1MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 0.2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 0.3MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** … | tablet | Non commercialisé | Sentynl Theraps INC |
| Duragesic-100 | 🇺🇸États-Unis | 100MCG/HR **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | film, extended release | Non commercialisé | Janssen Pharms |
| Duragesic-12 | 🇺🇸États-Unis | 12.5MCG/HR **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | film, extended release | Non commercialisé | Janssen Pharms |
| Duragesic-25 | 🇺🇸États-Unis | 25MCG/HR **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | film, extended release | Non commercialisé | Janssen Pharms |
| Duragesic-37 | 🇺🇸États-Unis | 37.5MCG/HR **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | film, extended release | Non commercialisé | Janssen Pharms |
